Collapsing glomerulopathy in Portugal: A review of the histological and clinical findings in HIV and non-HIV patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2209-2215

  Ferreira, Ana Carina ^a   Carvalho, Dulce ^a   Carvalho, Fernanda ^a,b   Galvo, Maria Joo ^b   Nolasco, Fernando ^a  

^a Department of Nephrology ^*  (Portugal)

^b HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

collapsing glomerulopathy; HIVAN; infections; renal biopsy

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENT COMPONENT C3; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ILLICIT DRUG; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ASSESSMENT; COLLAPSING GLOMERULOPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; ETHNIC GROUP; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PORTUGAL; PRIORITY JOURNAL; PROTEINURIA;

ADULT; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 79959940476     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq686     Document Type: Article

References (42)

1. Schwimmer JA, Markowitz GS, Valeri A et al. Collapsing glomerulopathy. Semin Nephrol 2003; 23: 209-218. (Pubitemid 36397103)
2. Grcevska L, Polenakovik M. Collapsing glomerulopathy: clinical characteristics and follow up. Am J Kidney Dis 1999; 33: 652-657. (Pubitemid 29159929)
3. Albaqumi M, Soos TJ, Barisoni L et al. Collapsing glomerulopathy. J Am Soc Nephrol 2006; 17: 2854-2863. (Pubitemid 44484675)
4. Meyrier AY. Collapsing glomerulopathy: expanding interest in a shrinking tuft. Am J Kidney Dis 1999; 33: 801-803. (Pubitemid 29159953)
5. Gherardi D, D'Agati V, Chu TH et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 2004; 15: 1212-1222. (Pubitemid 38526002)
6. Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non HIV patients: a clinicopathological and follow up study. Kidney Int 1999; 56: 2203-2213. (Pubitemid 30004749)
7. Weiss MA, Daquioag E, Margolin EG et al. Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathological entity? Am J Kidney Dis 1986; 7: 20-28. (Pubitemid 16157415)
8. Moudgil A, Nast CC, Bagga A et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-2133. (Pubitemid 32467604)
9. Tomlinson L, Boriskin Y, McPhee I et al. Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrol Dial Transplant 2003; 18: 187-189. (Pubitemid 36104498)
10. Markowitz GS, Appel GB, Fine PL et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001; 12: 1164-1172. (Pubitemid 32472629)
11. Markowitz GS, Fine PL, D'Agati VD. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 2002; 39: 1118-1122. (Pubitemid 34454233)
12. Barri YM, Munshi NC, Sukumalchantra S et al. Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 2004; 65: 634-641. (Pubitemid 38130659)
13. Pardo V, Aldana M, Colton RM et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 429-434. (Pubitemid 14018035)
14. Albaqumi M, Barisoni L. Current views on collapsing glomerulopathy. J Am Soc Nephrol 2008; 19: 1276-1281.
15. Shah SN, He CJ, Klotman P. Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 2006; 15: 450-455. (Pubitemid 44297989)
16. Ross MJ, Klotman PE. Recent progress in HIVassociated nephropathy. J Am Soc Nephrol 2002; 13: 2997-3004.
17. Szczech LA, Gupta SK, Habash R et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152. (Pubitemid 39121021)
18. Weiner NJ, Goodman JW, Kimmel PL. The HIV associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003; 63: 1618-1631. (Pubitemid 36513307)
19. Barisoni L, Schnaper W, Kopp J. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Nephrol 2007; 2: 529-542.
20. Appel D, Kershaw D, Smeets B et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009; 20: 333-343.
21. Bariety J, Mandet C, Hill GS et al. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006; 17: 2770-2780. (Pubitemid 44484667)
22. Romagnani P. Toward the identification of a "Renopoietic System"? Stem Cells 2009; 27: 2247-2253.
23. Smeets B, Angelotti ML, Rizzo P et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009; 20: 2593-2603.
24. Hughson MD, McManus JF, Hennigar GR. Studies on 'end-stage' kidneys. II. Embryonal hyperplasia of Bowman's capsular epithelium. Am J Pathol 1978; 91: 71-84.
25. Herlitz LC, Markowitz GS, Farris AB et al. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol 2010; 21: 163-172.
26. Yadav A, Vallabu S, Kumar D et al. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am J Physiol Renal Physiol 2010; 298: F734-F744.
27. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21: 1247-1253.
28. Al-Shamari A, Yeung K, Levin A et al. Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients. Am J Kidney Dis 2003; 42: 591-595. (Pubitemid 37048138)
29. Bruggeman LA, Ross MD, Tanji N et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11: 2079-2087.
30. Husain M, Gusella GL, Klotman ME et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 2002; 13: 1806-1815. (Pubitemid 34700605)
31. Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344: 1979-1984. (Pubitemid 32568152)
32. Avila-Casado Mdel C, Perez-Torres I, Auron A et al. Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 2004; 66: 133-143. (Pubitemid 38870089)
33. Appel GB. Personal communication in 32nd Annual Medicine Course -Renal Biopsy in Medical Diseases of the Kidneys. New York: Columbia University, August 2009.
34. Bitzan M, Ouahed JD, Krishnamoorthy P et al. Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution. Pediatr Nephrol 2008; 23: 355-361 Epub 2008 Mar 20.
35. Kaito H, Kamei K, Kikuchi E et al. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatr Nephrol 2010; 25: 957-959 Epub 2009 Dec 22.
36. Rodrigues CE, Sette LH, Torritani J et al. Tuberculosis-associated collapsing glomerulopathy: remission after treatment. Ren Fail 2010; 32: 143-146.
37. Schwartz EJ, Szczech LA, Ross MJ et al. Highly active antiretroviral therapy and the epidemic of HIV+ end stage renal disease. J Am Soc Nephrol 2005; 16: 2412-2420. (Pubitemid 41725059)
38. Wali RK, Drachenberg CI, Papadimitriou JC et al. HIV-1-associated nephropathy and response to highly active antiretroviral therapy. Lancet 1998; 352: 783-784. (Pubitemid 28404562)
39. Kirchner JT. Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature. AIDS Read 2002; 12: 103-105, 110-112.
40. Chemlal K, Nochy D, Kenouch S et al. Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 805-806. (Pubitemid 32295506)
41. Betjes MG, Verhagen DW. Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV-1-associated nephropathy. Nephrol Dial Transplant 2002; 17: 1836-1839. (Pubitemid 35174300)
42. FerreiraAC, CarvalhoD, Carvalho Fet al. Collapsing glomerulopathy -a treatable disease? Port J Nephrol Hypert 2008; 22: 255-258